Bellus Medical Announces CE Mark for Medical Microneedling Device and Accessories

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

Irrimax Receives FDA Clearance for Irrisept

"This new clearance from the FDA further solidifies Irrisept as the market leader in wound irrigation," said Mark Alvarez, CEO of Irrimax.

Bellus Medical, a leader in medical aesthetics, announced today that the company has completed CE Mark registration for its proprietary SkinPen® Microneedling Cartridge, a state-of-the art device used with the SkinPen® Precision Microneedling Pen and Skinfuse® Lift Hydrogel.

SkinPen® Precision is a microneedling device that utilizes Collagen Induction Therapy (CIT) to treat Melasma, acne and surgical scars (CE Intended Use).

“Receiving the CE Mark represents a significant milestone for Bellus Medical,” said President and CEO Joe Proctor. “When we started Bellus Medical in 2012, our goal was to create a company that was patient-focused, as well as product-focused. Today, we are an industry leader, a trusted provider, and now we can share that same level of service and commitment with our new partners in Europe.”

CE marking is a medical device manufacturer’s claim that a product meets the essential requirements of all relevant European Medical Device Directives (MDD). The directives outline the safety and performance requirements for medical devices in the European Union (EU). The CE Mark is a legal requirement to place a device on the market in the EU. The CE mark shows that Bellus Medical has complied with The European Medical Device Directive 93/42/EEC regarding medical devices.

“The aesthetics community has eagerly anticipated the expected quality improvements of devices in the microneedling category, and we look forward to the SkinPen® brand’s broad adoption in Europe,” Proctor said. “Providing practices in Europe with a safe, reliable and effective device is an accomplishment we are proud of. We are committed to providing cutting-edge, safe and high-quality devices, and we are thrilled about the opportunity to expand this commitment across Europe.”

With its ISO 13485:2016 Certification and CE Mark, Bellus Medical is expected to launch the SkinPen® microneedling system into Europe this year.




Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles